Neuroimplants to treat spinal cord injuriesA pioneering research study by researchers at the Institute of Molecular Biology & Biotechnology of FORTH and the University of Crete suggests the development of neuroimplants for the regeneration of nerve tissue in cases of spinal cord injury. The materials and cells used are non-toxic for humans, and approved from FDA for their immediate translation in humans.

FORTH coordinates the National Precision Medicine Network for Neurodegenerative DiseasesA new emblematic initiative, the National Network for Neurodegenerative Disease Research towards Precision Medicine, commences its operation in Greece. This flagship initiative positions Greece at the forefront of neurodegeneration and ageing research, with initial funding of € 2.2 million, over a two-year implementation period, provided by the Ministry of Development and Investments, through the General Secretariat for Research and Technology. The pioneering Network comprises leading National Research Centers and Universities, and is coordinated by the Foundation for Research and Technology - Hellas (FORTH), with the National and Kapodistrian University of Athens (NKUA) as co-coordinator.

Professor Spiros H. Anastasiadis in the Evaluation and Accreditation Council of the Hellenic Authority for Higher EducationDr. Spiros H. Anastasiadis, professor of Polymer Science and Engineering at the Department of Chemistry of the University of Crete and Director of the Institute of Electronic Structure and Laser of the Foundation for Research and Technology-Hellas, was elected a Member of the Evaluation and Accreditation Council of the Hellenic Authority for Higher Education (HAHE, www.ethaae.gr).

Population genomics insights into the recent evolution of SARS-CoV-2The coronavirus disease 2019 (COVID-19) pandemic, caused by SARS-CoV-2, still grows rapidly. A recent study published as a preprint manuscript in BioRxiv by researchers from FORTH-ICS, FORTH-IMBB and the University of Western Attica, provides new insights into the evolution of SARS-CoV-2 virus.